BUD — Budget/Appropriations
Outreach related to FY 2027 appropriations.
Lobbyists:
Government entities lobbied: SENATE
53d2fa77-195d-40a8-8f9f-ac69a3bbeb96Q1 — 1st Quarter - ReportARNOLD & PORTER KAYE SCHOLER LLP
Law firm
REGENERON PHARMACEUTICALS, INC.
Biopharmaceutical development and manufacturing
BUD — Budget/AppropriationsOutreach related to FY 2027 appropriations.
Government entities lobbied: SENATE
HCR — Health IssuesOutreach related to FY 2027 appropriations.
Government entities lobbied: SENATE
pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.